Tuberculosis: vaccines, diagnostics and experience
Tuberculosis remains one of the world’s deadliest infectious diseases, not least because of the prevalence of drug-resistant strains of TB. Researchers at the University of Oxford, supported by the NIHR Oxford Biomedical Research Centre (BRC), are tackling TB in a variety of ways, from vaccines to more targeted treatments.
Speakers:
Professor Helen McShane: Director of the Oxford NIHR Biomedical Research Centre; Professor of Vaccinology at Oxford University; Deputy Head (Translation and Personnel), Medical Sciences Division; and an Honorary Consultant Physician in Infectious Diseases.
Dr Philip Fowler: Associate Professor in the Modernising Medical Microbiology consortium in the Nuffield Department of Medicine; Cellular Life, Nuffield Department of Medicine
Produced by the NIHR Oxford Biomedical Research Centre.